Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Clinical trial NCT00657709 · COMPLETED
Trial details
- NCT number
- NCT00657709
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-01-01
- Enrollment
- 3630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.